ARCHITECT ESTRADIOL MASTERCHEK, MODEL # 6C22-05

K984604 · Bio-Rad · JJX · Feb 2, 1999 · Clinical Chemistry

Device Facts

Record IDK984604
Device NameARCHITECT ESTRADIOL MASTERCHEK, MODEL # 6C22-05
ApplicantBio-Rad
Product CodeJJX · Clinical Chemistry
Decision DateFeb 2, 1999
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.1660
Device ClassClass 1

Intended Use

Architect Estradiol MasterCheck is intended for use in the verification of sensitivity, calibration linearity, and reportable range of the Estradiol assay on the Abbott Architect i System.

Device Story

Architect Estradiol MasterCheck is a liquid control product used in clinical laboratory settings to verify the performance of the Estradiol assay on the Abbott Architect i System. The device consists of five levels (Level 0-4); Level 0 contains TRIS buffer with bovine protein stabilizers; Levels 1-4 contain estradiol prepared in the same buffer matrix with antimicrobial preservatives. Laboratory technicians use the product to assess calibration linearity, sensitivity, and the reportable range of the assay. By comparing the measured values of the MasterCheck levels against expected values, the healthcare provider confirms the accuracy and reliability of the diagnostic system, ensuring valid patient test results.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Liquid control material; matrix consists of TRIS buffer with bovine protein stabilizers and antimicrobial agents. Storage at 2-8°C. Open vial stability of 3 days at 2-8°C. Designed for use with the Abbott Architect i System.

Indications for Use

Indicated for use as a calibration verification material for the Estradiol assay on the Abbott Architect i System to verify sensitivity, linearity, and reportable range.

Regulatory Classification

Identification

A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo for Bio-Rad Laboratories, a company that manufactures and distributes products for the life science research and clinical diagnostics markets. The logo is black and white and features the company name in bold, sans-serif font. The logo is enclosed in a rounded rectangle. boratories one: (949) 598-1200 # 510(k) Summary Submitter Bio-Rad Laboratories 9500 Jeronimo Road Irvine, CA (949)598-1285 Fax (949)598-1555 Contact Person Elizabeth Platt Date of Summary Preparation December 21, 1998 Device (Trade & Common Name) Architect Estradiol MasterCheck Classification Name Class I, 75JJX CFR 862.1660: Single (Specified) Analyte Controls (Assayed and Unassayed) Devices to Which Substantial Equivalence is Claimed Document Serum Multi-Analyte Verification Test Set Casco Standards Yarmouth, ME K950469 #### Statement of Intended Use Architect Estradiol MasterCheck is intended for use in the verification of sensitivity, calibration linearity, and reportable range of the Estradiol assay on the Abbett Architect i System. {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the logo for Bio-Rad Laboratories. The logo consists of the text "BIO-RAD" in a bold, sans-serif font. The text is white and is set against a black, rounded rectangle. Blo-Rad Laboratories Diagnostics Gmun Irvine, California 92618-2017 Telephone: (949) 598-1200 #### Description of the Device Architect Estradiol MasterCheck Level 0 contains TRIS buffer with protein (bovine) stabilizers. Architect Estradiol MasterCheck Levels 1, 2, 3 and 4 contain estradiol prepared in TRIS buffer with protein (bovine) stabilizers. :: Preservative: Antimicrobial Agent. ### Statement of How Technological Characteristics Compare to Substantial Equivalence Device A table is provided below comparing the similarities between the Bio-Rad Architect Estradiol MasterCheck and the devices to which substantial equivalence is claimed. | | Architect Estradiol MasterCheck | Casco Standards Document<br>Serum Multi-Analyte<br>Verification Test Set | |--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Intended<br>Use | Verification of sensitivity,<br>calibration linearity, and<br>reportable range of the Estradiol<br>assay on the Abbott Architect i<br>System. | In vitro diagnostic use in the<br>quantitative determination of<br>linearity, calibration<br>verification and verification<br>of reportable range using<br>automated, semi-automated<br>and manual methods. | | Form | Liquid | Liquid | | Matrix | TRIS buffer with protein (bovine)<br>stabilizers. | Human Serum | | Storage | 2-8°C | -10 to -20°C | | Analytes | Estradiol | Multiple | | Open Vial<br>Claim | 3 Days at 2-8°C. | 30 Days at 2-8°C. | | Differences | Calibration verifier for the<br>Architect Estradiol assay. | Calibration verifier for<br>multiple analytes. | {2}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/2 description: The image shows a stylized logo or emblem, possibly associated with a department or organization. The logo features a series of three curved, overlapping shapes that resemble stylized waves or swooshes. The text "DEPART" is oriented vertically and rotated, and the text "OF HEALTH & HUMAN" is also oriented vertically and rotated. 2 1999 EEB Food and Drug Administration 2098 Gaither Road Rockville MD 20850 Ms. Elizabeth Platt Regulatory Affairs Supervisor Bio-Rad Laboratories Diagnostics Group 9500 Jeronimo Road Irvine, California 92618-2017 K984604 Re: Trade Name: Architect™ Estradiol MasterCheck Regulatory Class: I Product Code: JJX Dated: December 21, 1998 Received: December 28, 1998 Dear Ms. Platt: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce stated in also 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls Connistions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3}------------------------------------------------ #### Page 2 Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitto diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Steven Butman Steven I. Gutman, M.D, M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health V Enclosure {4}------------------------------------------------ Page 1 of 1 3 510(k) Number: K984604 Device Name: Architect Estradiol MasterCheck Indications for Use: Architect Estradiol MasterCheck is intended for use in the verification of sensitivity, calibration linearity, and reportable range of the Estradiol assay on the Abbott Architect i System. Sean Cooper u: Sign-Off) on of Clinical Laboratory Devices K984604 Ak) Mumber (Please Do NOT WRITE BELOW THE LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) (Concurrence of CDRH, Office of Device Evaluation) Prescription Use \checkmark OR Over-The Counter Use **__**
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...